glp-1 and vision Medications NAION: What Patients Should Know About Sudden Loss GLP-1 Medications and Your Eye

But as of May 23, 2025, no new compounded semaglutide is legally permitted to be produced or sold

Direct comparisons are rarer than the internet suggests

STEP 1 study group

Practical Recommendations for Clinicians Given the inconclusive data on bone safety during GLP1 treatment, clinicians should: Assess fracture risk using tools like FRAX before starting therapy Order BMD tests for patients with osteoporosis risk factors Monitor for excessive or rapid weight loss that may compromise bone mass Promote calcium and vitamin D intake, resistance training, and fall prevention strategies Refer to endocrinologists or bone specialists as needed for complex cases Future Research Questions Several questions remain unanswered about how GLP1 medications influence longterm bone integrity: Do individual GLP1 agents differ in their effects on bone remodeling

She said the prevalence of commercials on TV, phones and modern platforms can create confusion about whats real and whats fake while delivering unrealistic expectations because not all weight-loss drugs are Food and Drug Administration approved